NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	32.29M
Revenue (ttm)	4.68M
Net Income (ttm)	-10.10M
Shares Out	23.92M
EPS (ttm)	-0.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,260
Open	1.36
Previous Close	1.35
Day's Range	1.30 - 1.36
52-Week Range	0.85 - 2.87
Beta	0.69
Analysts	Strong Buy
Price Target	2.20 (+67.94%)
Earnings Date	Dec 12, 2023

About NMTC

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with R...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC

Financial Performance

In 2022, NMTC's revenue was $2.12 million, an increase of 772.60% compared to the previous year's $242,958. Losses were -$10.00 million, 0.52% more than in 2021.

Analyst Forecast

According to one analyst, the rating for NMTC stock is "Strong Buy" and the 12-month stock price forecast is $2.2.

Price Target

$2.2

(67.94% upside)

Analyst Consensus: Strong Buy